These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 15920167

  • 1. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.
    Gordon GJ, Rockwell GN, Jensen RV, Rheinwald JG, Glickman JN, Aronson JP, Pottorf BJ, Nitz MD, Richards WG, Sugarbaker DJ, Bueno R.
    Am J Pathol; 2005 Jun; 166(6):1827-40. PubMed ID: 15920167
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma.
    Cheng YY, Wright CM, Kirschner MB, Williams M, Sarun KH, Sytnyk V, Leshchynska I, Edelman JJ, Vallely MP, McCaughan BC, Klebe S, van Zandwijk N, Lin RC, Reid G.
    Mol Cancer; 2016 Jun 01; 15(1):44. PubMed ID: 27245839
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Validation of genomics-based prognostic tests in malignant pleural mesothelioma.
    Gordon GJ, Rockwell GN, Godfrey PA, Jensen RV, Glickman JN, Yeap BY, Richards WG, Sugarbaker DJ, Bueno R.
    Clin Cancer Res; 2005 Jun 15; 11(12):4406-14. PubMed ID: 15958625
    [Abstract] [Full Text] [Related]

  • 9. Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE).
    Wali A, Morin PJ, Hough CD, Lonardo F, Seya T, Carbone M, Pass HI.
    Lung Cancer; 2005 Apr 15; 48(1):19-29. PubMed ID: 15777968
    [Abstract] [Full Text] [Related]

  • 10. Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells.
    Mohr S, Bottin MC, Lannes B, Neuville A, Bellocq JP, Keith G, Rihn BH.
    Biochimie; 2004 Jan 15; 86(1):13-9. PubMed ID: 14987796
    [Abstract] [Full Text] [Related]

  • 11. Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.
    Dong L, Jensen RV, De Rienzo A, Gordon GJ, Xu Y, Sugarbaker DJ, Bueno R.
    BMC Med Genet; 2009 Dec 31; 10():149. PubMed ID: 20043850
    [Abstract] [Full Text] [Related]

  • 12. Pathogenesis of malignant pleural mesothelioma.
    Jaurand MC, Fleury-Feith J.
    Respirology; 2005 Jan 31; 10(1):2-8. PubMed ID: 15691231
    [Abstract] [Full Text] [Related]

  • 13. Wnt2 as a new therapeutic target in malignant pleural mesothelioma.
    Mazieres J, You L, He B, Xu Z, Twogood S, Lee AY, Reguart N, Batra S, Mikami I, Jablons DM.
    Int J Cancer; 2005 Nov 01; 117(2):326-32. PubMed ID: 15900580
    [Abstract] [Full Text] [Related]

  • 14. [Gene expression profiling in human mesothelioma cells using DNA microarray and high-density filter array technologies].
    Mohr S, Rihn B.
    Bull Cancer; 2001 Mar 01; 88(3):305-13. PubMed ID: 11313208
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Kinesin family members KIF11 and KIF23 as potential therapeutic targets in malignant pleural mesothelioma.
    Kato T, Lee D, Wu L, Patel P, Young AJ, Wada H, Hu HP, Ujiie H, Kaji M, Kano S, Matsuge S, Domen H, Kaga K, Matsui Y, Kanno H, Hatanaka Y, Hatanaka KC, Matsuno Y, de Perrot M, Yasufuku K.
    Int J Oncol; 2016 Aug 01; 49(2):448-56. PubMed ID: 27279560
    [Abstract] [Full Text] [Related]

  • 17. Genetics of malignant pleural mesothelioma: molecular markers and biologic targets.
    Bueno R, Gordon GJ.
    Thorac Surg Clin; 2004 Nov 01; 14(4):461-8. PubMed ID: 15559052
    [Abstract] [Full Text] [Related]

  • 18. Cell protection, resistance and invasiveness of two malignant mesotheliomas as assessed by 10K-microarray.
    Mohr S, Keith G, Galateau-Salle F, Icard P, Rihn BH.
    Biochim Biophys Acta; 2004 Jan 20; 1688(1):43-60. PubMed ID: 14732480
    [Abstract] [Full Text] [Related]

  • 19. Gene expression profile of aquaporin 1 and associated interactors in malignant pleural mesothelioma.
    Jagirdar R, Solenov EI, Hatzoglou C, Molyvdas PA, Gourgoulianis KI, Zarogiannis SG.
    Gene; 2013 Mar 15; 517(1):99-105. PubMed ID: 23313295
    [Abstract] [Full Text] [Related]

  • 20. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
    Goto Y, Shinjo K, Kondo Y, Shen L, Toyota M, Suzuki H, Gao W, An B, Fujii M, Murakami H, Osada H, Taniguchi T, Usami N, Kondo M, Hasegawa Y, Shimokata K, Matsuo K, Hida T, Fujimoto N, Kishimoto T, Issa JP, Sekido Y.
    Cancer Res; 2009 Dec 01; 69(23):9073-82. PubMed ID: 19887624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.